Funding Details
- Awarder
- SOSV
- Date Award
- May 13, 2024
- Vertical
- Therapeutics
- Funding URL
- View Funding Page
Company Info
- Organizations Involved
- U.S. Air Force, Bain Capital, SpaceX, Lockheed Martin
- Founders
- Scott Dixon, Davide Zanchi
- Company Description
- Prothegen is developing therapeutics to inhibit or promote ferroptosis, a new type of cell death involved in major life-threatening diseases. Ferroptosis is an iron-mediated failure of antioxidant defenses. Now, Prothegen is developing drugs that stop cells from dying of ferroptosis.
- Market
- Human Health
- Location
-
United States
Links